Catecholamines in urine after death

W P Tormey1, M Carney, R J FitzGerald

  • 1Department of Chemical Pathology, Beaumont Hospital, Dublin, Ireland.

Insights

This study measured catecholamine levels in autopsy urine, finding elevated noradrenaline and adrenaline in most cases. These stress markers showed no significant difference between myocardial infarction and trauma deaths.

Area of Science:

  • Forensic Medicine
  • Clinical Chemistry
  • Toxicology

Background:

  • Catecholamine levels in urine can indicate physiological stress.
  • Autopsy studies provide insights into post-mortem biochemical changes.

Purpose of the Study:

  • To measure noradrenaline, adrenaline, and dopamine levels in autopsy urine.
  • To compare these levels with essential hypertension reference values.
  • To investigate differences in catecholamine levels between causes of death.

Main Methods:

  • Analysis of 30 unselected autopsy urine specimens.
  • High-performance liquid chromatography (HPLC) with electrochemical detection.
  • Measurement of catecholamines relative to urine creatinine.

Main Results:

  • Elevated noradrenaline (76.6%), adrenaline (80%), and dopamine (23.3%) were observed compared to hypertension reference values.
  • No significant difference in median noradrenaline or adrenaline levels between myocardial infarction and trauma deaths.
  • Autopsy noradrenaline values overlapped with normal subjects and phaeochromocytoma cases.

Conclusions:

  • Autopsy urine catecholamine levels are frequently elevated, suggesting physiological stress prior to death.
  • Myocardial infarction and severe trauma do not show distinct post-mortem urine catecholamine profiles.
  • Further research is needed to interpret these findings in relation to specific pathologies.

Related Concept Videos

Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...